Skip to content

The real world study of TCM treatment based on syndrome differentiation in patients recovering from COVID-19 infection

The real world study of TCM treatment based on syndrome differentiation in patients recovering from COVID-19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001974
Enrollment
Unknown
Registered
2025-10-22
Start date
2023-05-26
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID-19 condition

Interventions

Treatment group:The Western medical treatment plan was the same as that of the control group and at the same time the recommended prescription for the recovery period based on traditional Chinese medi
Control group:According to the conventional symptomatic treatment of Western medicine during the recovery period of COVID-19 infection such as relieving asthma stopping cough and expectorating phlegm

Sponsors

Guangdong Provincial Hospital of Chinese Medicine Zhuhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria for the syndrome types of novel coronavirus infection in Western medicine and traditional Chinese medicine. (2) Age: 18 to 80 years old. (3) Normal communication and expression skills capable of cooperating to complete the treatment and follow-up of observation indicators. (4) The selected cases obtained the informed consent of the patients.

Exclusion criteria

Exclusion criteria: (1) Those who are taking other traditional Chinese medicine preparations simultaneously or have entered other research projects at the same time. (2) Pregnant or lactating women. (3) Those with allergic constitutions or allergic reactions to the treatment drugs for this project. (4) There are serious primary diseases such as liver kidney and hematopoietic system comorbidities. (5) Those with relatively severe chronic hypoxic diseases such as uncontrolled bronchial asthma chronic obstructive pulmonary disease sleep apnea and respiratory failure.

Design outcomes

Primary

MeasureTime frame
Score of the Traditional Chinese Medicine Symptom Score Scale;

Secondary

MeasureTime frame
Troponin;NYHA Cardiac Function Classification;Chest CT;Blood gas analysis;Blood routine examination;Urinalysis;D-dimer;proBNP;Myocardial enzyme;C-reactive protein;SF-36 Quality of Life Scoring Scale;Chest X-ray;

Countries

China

Contacts

Public ContactXi Xiaotu

Guangdong Provincial Hospital of Chinese Medicine Dade Road General Hospital

xixiaotu@163.com+86 139 2955 6092

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026